Why the study?
Does adenovirus-mediated gene transfer of C-type natriuretic peptide improve reendothelialization and reduce thrombogenicity and neointimal hyperplasia in rabbit vein grafts?
Does adenovirus-mediated gene transfer of C-type natriuretic peptide improve reendothelialization and reduce thrombogenicity and neointimal hyperplasia in rabbit vein grafts?
Answers are grounded in this paper and cite their sources.
Adenovirus-mediated gene transfer of CNP accelerates reendothelialization and suppresses thrombosis and neointimal hyperplasia in a rabbit vein graft model, suggesting a potential strategy to prevent vein graft disease.
BACKGROUND: Vein graft disease limits the late results of coronary revascularization. C-type natriuretic peptide (CNP) inhibits the growth of vascular smooth muscle cells. Given the effects of CNP on cGMP cascade, we hypothesized that transfected CNP genes modulate endothelial repair and thrombogenicity in the vein graft. METHODS AND RESULTS: Autologous rabbit jugular vein grafts were incubated ex vivo in a solution of adenovirus vectors containing CNP gene (Ad.CNP) or Escherichia coli lac Z gene (Ad.LacZ) and then interposed in the carotid artery. Reendothelialization, mural thrombi formation, and intima/media ratio were evaluated on the 14th and 28th postoperative days. More reendothelialization was seen in Ad.CNP-infected grafts than in Ad.LacZ-infected grafts both at 14 days (0.81+/-0.05 versus 0.30+/-0.14, P<0.01) and at 28 days (0.96+/-0.01 versus 0.45+/-0.08, P<0.001). The mural thrombus area was smaller in Ad.CNP-infected grafts than in Ad.LacZ-infected grafts. Neointimal thickening was significantly suppressed in the Ad.CNP group. The in vitro wound assay with human coronary artery endothelial cells revealed significant potentiation of the wound repair process by CNP and atrial natriuretic peptide administration. CONCLUSIONS: Infected Ad.CNP accelerated reendothelialization and suppressed thrombosis and neointimal hyperplasia. The method may potentially prevent vein graft disease in patients undergoing coronary artery revascularization.
No takes yet. Share an insight, caveat, or question.
Ohno et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: